FIGURE

Figure 3

ID
ZDB-FIG-200817-33
Publication
Creusot et al., 2020 - The Anti-Cancer Drug Dabrafenib Is a Potent Activator of the Human Pregnane X Receptor
Other Figures
All Figure Page
Back to All Figure Page
Figure 3

Dabrafenib binds to hPXR. Inhibition of FRET between fluorescein-labeled PXR ligand and recombinant GST-hPXR by SR12813 or dabrafenib. Results are expressed as the signal from the fluorescein emission divided by the terbium signal to provide a TR-FRET emission ratio. Data are the mean (±sd) from three independent experiments, *** p < 0.001, ** p < 0.01, * p < 0.1 (Student’s t-test) compared with DMSO-treated cells.3.3. Induction of hPXR-Mediated Proliferation by Dabrafenib.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cells